210 related articles for article (PubMed ID: 29199006)
21. RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma.
Jiang C; Song T; Li J; Ao F; Gong X; Lu Y; Zhang C; Chen L; Liu Y; He H; Huang O
Mol Neurobiol; 2017 Jan; 54(1):779-787. PubMed ID: 27021020
[TBL] [Abstract][Full Text] [Related]
22. Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma.
Nakano T; Fujimoto K; Tomiyama A; Takahashi M; Achiha T; Arita H; Kawauchi D; Yasukawa M; Masutomi K; Kondo A; Narita Y; Maehara T; Ichimura K
Cancer Sci; 2022 Feb; 113(2):697-708. PubMed ID: 34839570
[TBL] [Abstract][Full Text] [Related]
23. Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth.
Das A; Alshareef M; Henderson F; Martinez Santos JL; Vandergrift WA; Lindhorst SM; Varma AK; Infinger L; Patel SJ; Cachia D
Clin Transl Oncol; 2020 Jul; 22(7):1138-1145. PubMed ID: 31732915
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma.
Maggio D; Ho WS; Breese R; Walbridge S; Wang H; Cui J; Heiss JD; Gilbert MR; Kovach JS; Lu RO; Zhuang Z
J Neurooncol; 2020 Jun; 148(2):231-244. PubMed ID: 32342332
[TBL] [Abstract][Full Text] [Related]
25. mTORC1 inhibitors suppress meningioma growth in mouse models.
Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
[TBL] [Abstract][Full Text] [Related]
26. A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.
Nigim F; Esaki S; Hood M; Lelic N; James MF; Ramesh V; Stemmer-Rachamimov A; Cahill DP; Brastianos PK; Rabkin SD; Martuza RL; Wakimoto H
Neuro Oncol; 2016 Sep; 18(9):1278-87. PubMed ID: 26951380
[TBL] [Abstract][Full Text] [Related]
27. The integrin inhibitor cilengitide affects meningioma cell motility and invasion.
Wilisch-Neumann A; Kliese N; Pachow D; Schneider T; Warnke JP; Braunsdorf WE; Böhmer FD; Hass P; Pasemann D; Helbing C; Kirches E; Mawrin C
Clin Cancer Res; 2013 Oct; 19(19):5402-12. PubMed ID: 23948974
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics.
Hu B; Hao S; Miao Y; Deng Y; Wang J; Wan H; Zhang S; Ji N; Feng J
Pathol Oncol Res; 2022; 28():1610572. PubMed ID: 36203966
[TBL] [Abstract][Full Text] [Related]
29. Management of Atypical and Anaplastic Meningiomas.
Buttrick S; Shah AH; Komotar RJ; Ivan ME
Neurosurg Clin N Am; 2016 Apr; 27(2):239-47. PubMed ID: 27012388
[TBL] [Abstract][Full Text] [Related]
30. Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line.
Kondraganti S; Gondi CS; Gujrati M; McCutcheon I; Dinh DH; Rao JS; Olivero WC
Int J Oncol; 2006 Jul; 29(1):25-32. PubMed ID: 16773181
[TBL] [Abstract][Full Text] [Related]
31. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms.
Lu J; Kovach JS; Johnson F; Chiang J; Hodes R; Lonser R; Zhuang Z
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11697-702. PubMed ID: 19564615
[TBL] [Abstract][Full Text] [Related]
33. Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
Gupta V; Su YS; Samuelson CG; Liebes LF; Chamberlain MC; Hofman FM; Schönthal AH; Chen TC
J Neurosurg; 2007 Mar; 106(3):455-62. PubMed ID: 17367069
[TBL] [Abstract][Full Text] [Related]
34. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
[TBL] [Abstract][Full Text] [Related]
35. Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor.
Lee YE; Choi SA; Kwack PA; Kim HJ; Kim IH; Wang KC; Phi JH; Lee JY; Chong S; Park SH; Park KD; Hwang DW; Joo KM; Kim SK
Neuro Oncol; 2017 Aug; 19(8):1079-1087. PubMed ID: 28340172
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repair.
Wei D; Parsels LA; Karnak D; Davis MA; Parsels JD; Marsh AC; Zhao L; Maybaum J; Lawrence TS; Sun Y; Morgan MA
Clin Cancer Res; 2013 Aug; 19(16):4422-32. PubMed ID: 23780887
[TBL] [Abstract][Full Text] [Related]
37. SU11657 enhances radiosensitivity of human meningioma cells.
Milker-Zabel S; Zabel-du Bois A; Ranai G; Trinh T; Unterberg A; Debus J; Lipson KE; Abdollahi A; Huber PE
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1213-8. PubMed ID: 18234428
[TBL] [Abstract][Full Text] [Related]
38. NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.
Kotipatruni RP; Ferraro DJ; Ren X; Vanderwaal RP; Thotala DK; Hallahan DE; Jaboin JJ
Integr Biol (Camb); 2012 Oct; 4(10):1185-97. PubMed ID: 22869042
[TBL] [Abstract][Full Text] [Related]
39. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth.
McCutcheon IE; Friend KE; Gerdes TM; Zhang BM; Wildrick DM; Fuller GN
J Neurosurg; 2000 Feb; 92(2):306-14. PubMed ID: 10659019
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the cell lines used in meningioma research.
Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
